HK1054683B - 可凍乾和增强的壓縮核酸 - Google Patents

可凍乾和增强的壓縮核酸

Info

Publication number
HK1054683B
HK1054683B HK03106578.4A HK03106578A HK1054683B HK 1054683 B HK1054683 B HK 1054683B HK 03106578 A HK03106578 A HK 03106578A HK 1054683 B HK1054683 B HK 1054683B
Authority
HK
Hong Kong
Prior art keywords
nucleic acids
shape
compacted nucleic
lyophilizable
enhanced
Prior art date
Application number
HK03106578.4A
Other languages
English (en)
Other versions
HK1054683A1 (en
Inventor
Mark J Cooper
Thomasz H Kowalczyk
Murali K Pasumarthy
Maureen Costello
Original Assignee
Copernicus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Copernicus Therapeutics Inc filed Critical Copernicus Therapeutics Inc
Publication of HK1054683A1 publication Critical patent/HK1054683A1/xx
Publication of HK1054683B publication Critical patent/HK1054683B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47—Scattering, i.e. diffuse reflection
    • G01N21/49—Scattering, i.e. diffuse reflection within a body or fluid
    • G01N21/51—Scattering, i.e. diffuse reflection within a body or fluid inside a container, e.g. in an ampoule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK03106578.4A 2000-05-31 2003-09-13 可凍乾和增强的壓縮核酸 HK1054683B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20794900P 2000-05-31 2000-05-31
US28741901P 2001-05-01 2001-05-01
PCT/US2001/017499 WO2001092580A2 (en) 2000-05-31 2001-05-31 Lyophilizable and enhanced compacted nucleic acids

Publications (2)

Publication Number Publication Date
HK1054683A1 HK1054683A1 (en) 2003-12-12
HK1054683B true HK1054683B (zh) 2009-02-06

Family

ID=26902762

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106578.4A HK1054683B (zh) 2000-05-31 2003-09-13 可凍乾和增强的壓縮核酸

Country Status (9)

Country Link
EP (1) EP1289567B1 (zh)
JP (1) JP2003534811A (zh)
AT (1) ATE402718T1 (zh)
AU (2) AU6520801A (zh)
CA (1) CA2410265A1 (zh)
DE (1) DE60135115D1 (zh)
ES (1) ES2311522T3 (zh)
HK (1) HK1054683B (zh)
WO (1) WO2001092580A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359228B1 (en) * 2002-04-23 2013-11-27 Accenture Global Services Limited DNA authentification based on scattered-light detection
WO2011053660A2 (en) 2009-10-30 2011-05-05 Gradalis, Inc. Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025809A1 (en) * 1994-03-23 1995-09-28 Ohio University Compacted nucleic acids and their delivery to cells
US5994316A (en) * 1996-02-21 1999-11-30 The Immune Response Corporation Method of preparing polynucleotide-carrier complexes for delivery to cells
US5948878A (en) * 1997-04-15 1999-09-07 Burgess; Stephen W. Cationic polymers for nucleic acid transfection and bioactive agent delivery
US7683035B1 (en) * 1999-02-23 2010-03-23 Qiagen, Gmbh Method of stabilizing and/or isolating nucleic acids

Also Published As

Publication number Publication date
EP1289567A2 (en) 2003-03-12
AU6520801A (en) 2001-12-11
HK1054683A1 (en) 2003-12-12
WO2001092580A2 (en) 2001-12-06
DE60135115D1 (de) 2008-09-11
WO2001092580A3 (en) 2002-05-30
ES2311522T3 (es) 2009-02-16
AU2001265208B2 (en) 2006-08-17
EP1289567B1 (en) 2008-07-30
CA2410265A1 (en) 2001-12-06
JP2003534811A (ja) 2003-11-25
ATE402718T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
Mohseni et al. Development of a label-free SPR sensor for detection of matrixmetalloproteinase-9 by antibody immobilization on carboxymethyldextran chip
Osborne et al. An improved method for the purification of carbonic anhydrase isozymes by affinity chromatography
EP0454044A3 (en) Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
FI955319A0 (fi) 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina
TR200002338T2 (tr) Stratejik olarak yenilenmiş hepatit B çekirdek proteinler.
DE69532532T8 (de) Chimerische papillomavirus-ahnliche partikel
ATE181234T1 (de) Phospholipid-beschichtete mikrokristalle: injizierbare formulierungen wasserlöslicher arzneimittel
IL149116A0 (en) Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
HK1054683A1 (en) Lyophilizable and enhanced compacted nucleic acids
ATE269405T1 (de) Tnf-alpha ribozyme und abbau-resistente mrna derivative gebunden an tnf-alpha ribozyme
Chattoraj et al. Position of two deletion mutations on the physical map of bacteriophage P2
GR3036634T3 (en) Novel protein polycation conjugates.
Duranton et al. Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA
Chaproniere-Rickenberg et al. The interaction of DNA and internal protein from coliphage T2
Clarke et al. A simple and general route for monofunctionalization of fluorescent and magnetic nanoparticles using peptides
Li et al. Helix–coil transition in nucleoprotein. Effect of ionic strength on thermal denaturation of polylysine–DNA complexes
FR2808705B1 (fr) Composition pulverulente d'hydrocolloides presentant une dispersabilite amelioree en milieu aqueux et procede pour leur preparation
ATE402261T1 (de) Partikel zur gentherapie
ATE274901T1 (de) Liposomen enthaltend einen komplex aus polyanion und calciumphosphat
Yang et al. EGF receptor in human Chang liver and hepatoma HepG2 cells
Agrawal Expression of viral and cellular genes in bovine papillomavirus transformation and their role in virus-induced tumourigenesis.
KR100492292B1 (ko) 유전자의 세포내 도입을 위한 인산칼슘/핵산 복합체의 제조방법
Vijayalatha et al. Voltammetric study of chlorpromazine-copper interactions
WO1994011510A3 (en) Modulators of hematopoietic progenitor cells
JPS6490044A (en) Shaking culture flask

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140531